| Dr Charity Elaine Clifford, LMFT | |
|
155 S 18th St, Ste 200, Kansas City, KS 66102-5642 | |
| (801) 502-8492 | |
| Not Available |
| Full Name | Dr Charity Elaine Clifford |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 155 S 18th St, Kansas City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851836530 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 2591 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charity Elaine Clifford, LMFT Po Box 13115, Overland Park, KS 66282-3115 Ph: (913) 488-2178 | Dr Charity Elaine Clifford, LMFT 155 S 18th St, Ste 200, Kansas City, KS 66102-5642 Ph: (801) 502-8492 |
News Archive
Over 3,500 Australians were hospitalised due to contact with a venomous animal or plant in 2017–18, according to a new report released today by the Australian Institute of Health and Welfare (AIHW).
A new study finds that propofol, a well-known anesthesia medication, has a low occurrence of adverse events for children undergoing research-driven imaging studies. The study, led by a pediatric anesthesiologist now at Children's National Medical Center, showed a low incidence of adverse events and no long term complications when propofol was used to sedate children for imaging studies that require them to be still for long periods of time.
GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.
Northwest Biotherapeutics announced today that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom, for the Company's 300-patient Phase III clinical trial of DCVax-L immune therapy for Glioblastoma multiforme brain cancer (GBM) to proceed in the U.K.
› Verified 3 days ago
Mrs. Andrea Campbell, LMFT-T Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7840 Washington Ave, Kansas City, KS 66112 Phone: 913-563-6500 Fax: 913-328-4604 | |
Diane Victory, LCMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7840 Washington Ave, Kansas City, KS 66112 Phone: 913-563-6500 | |
Dr. Linda Buxbaum Bass, PHD, LCMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 155 S 18th St, Suite 222, Kansas City, KS 66102 Phone: 913-963-0784 | |
Mr. Jared Lloyd Cristy, TLMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 757 Armstrong Ave, Kansas City, KS 66101 Phone: 913-233-3336 | |
Bronwyn Burkhardt, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1301 N 47th St, Kansas City, KS 66102 Phone: 816-969-0531 | |
Mary V Henton, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7840 Washington Ave, Kansas City, KS 66112 Phone: 913-233-3303 Fax: 913-233-3350 | |
Justin J Bastin, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 2300 Hutton Rd Ste 112, Kansas City, KS 66109 Phone: 816-343-8452 Fax: 913-745-6155 |